Financial statements Biophage Pharma
Balance sheet of Biophage Pharma
Company age:
Age:
12 y. 11 m. 1 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of BIOPHAGE PHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 521 176,17 | 740 081,78 | 378 035,02 | 205 249,79 | 468 490,36 |
| A. Fixed assets | 297 432,58 | 183 011,15 | 64 892,17 | 13 949,66 | 0,00 |
| B. Current assets | 223 743,59 | 557 070,63 | 313 142,85 | 191 300,13 | 468 490,36 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 521 176,17 | 740 081,78 | 378 035,02 | 205 249,79 | 468 490,36 |
| A. Equity | 440 789,26 | 492 599,71 | 311 340,54 | 126 960,40 | 409 790,81 |
| B. Liabilities and provisions for liabilities | 80 386,91 | 247 482,07 | 66 694,48 | 78 289,39 | 58 699,55 |
| I. Long-term liabilities | 0,00 | 156 750,00 | 21 472,46 | 0,00 | 0,00 |
| II. Short-term liabilities | 69 765,35 | 88 548,67 | 45 222,02 | 72 889,39 | 58 699,55 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.